Ha Lipampiri li Qotsa Vendor Vectors: Mokhoa oa ho bala Litemana tsa Reagent (Thuto-pale: GenScript pcDNA3 ho Patlisiso ea MDM2)
Ha bafuputsi ba ka sehloohong le bo-ramahlale ba phahameng ba lipatlisiso ba bala lingoliloeng tse sa tsoa hatisoa ho oncology kapa cell biology., mantsoe a qotsitsoeng a barekisi hangata a nkuoa e le setempe se hlakileng sa tumello. Ho bona vector ea khoebo ea mammalian kapa peptide ea moetlo e qotsitsoeng lipampiring tse mashome a mabeli tse hlahlobiloeng ke lithaka ho theha mohopolo oa ho ts'epahala.. Haeba lilaboratori tse ngata tse ikemetseng li lula li reka mofuta o itseng oa GenScript pcDNA3 vector kapa peptide ea maiketsetso ea khoebo ho ithuta pontšo ea MDM2-p53., ho bonahala ho utloahala ho odara nomoro e tšoanang ea lethathamo le ho tsoela pele ka kotloloho ho ts'ebetsong ea benche.
Leha ho le joalo, ho nka liqoso tsa barekisi e le moemeli oa boleng ba batch e matla ke e 'ngoe ea lisosa tse atileng haholo tsa data ea laboratori e ke keng ea qojoa.. Litlhaloso tse hlahang likoranteng tse hlahlobiloeng ke lithaka li tlaleha tšebeliso ea histori, eseng haholo-holo 'meleng, khemikhale, kapa netefatso ya tshebetso. Mekotla ea plasmid ea khoebo e ba le litlhahlobo tsa tatellano ea barekisi, ho feta ka mefuta e mengata ho hlahisa mefuta e fokolang ea batho, le li-vector tsa polelo tse tsamaisoang ke bahlahisi ba vaerase li ka sebetsa ka mokhoa o sa lebelloang ho latela semelo sa liphatsa tsa lefutso tsa cellular..
Ho sireletsa boitlhakiso ba liteko ho hloka ho ithuta ho bala litemana tse qotsitsoeng ka mokhoa o hlokolosi le ho sebelisa tse ikemetseng., taolo ea boleng ba orthogonal (QC) protocol pele o sebelisa reagent efe kapa efe e sebelisoang ke lingoliloeng.
Litlhaloso tsa Barekisi ba Khoebo vs. Litšehetso tsa Ketsahalo: Ho senya Matšoao a Tšepahalang a sa Tobang
Ho hlahloba lisebelisoa tse tsoang mehloling ea lingoliloeng ka katleho, lilaboratori li tlameha ho khetholla lipakeng tsa matšoao a fapaneng a khoebo. Khatisong ea mahlale, morekisi o bua ka, qotsa database, 'me litšehetso tsa liketsahalo li fana ka mesebetsi e ikhethang ea tsamaiso le ea papatso, empa ha ho le e 'ngoe ea tsona e tiisang hore lotho e ncha e tsoang ho morekisi oa khoebo e tla sebetsa ka mokhoa o ts'oanang tlhahlobong ea hau.
Lingoliloeng Ho Bolela / RRID → Tlaleho ea Tšebeliso ea Histori (Moo e neng e rekoa teng)
Tšehetso ea Barekisi → Letšoao la Lipapatso tsa Khoebo (Ponahalo ea lebitso)
Orthogonal QC & CoA → Empirical Verification (Boitsebiso bo itseng bo bongata & bohloeki)
Litlhaloso tsa Lingoliloeng le Litlhahiso tsa Mehloli ea Lipatlisiso (Li-RRID)
Ha pampiri e thathamisa nomoro ea lethathamo kapa Setsi sa Mohloli oa Lipatlisiso (KE BATLA), e theha traceability bakeng sa data e hatisitsoeng. Mekhoa e tloaelehileng ea ho qotsa e khothalletsa bonnete le ho ba le matla a ho ikatisa ka ho lumella babali ho latela mokhoa oa ho sebelisa lisebelisoa ho pholletsa le lithuto., joalo ka ha ho totobalitsoe ho Tataiso ea phatlalatso ea NIH mabapi le netefatso le lintlha tse qotsitsoeng.
Li-platform tsa merafo tse kang CiteAb li kopanya litemana tsena ho lekanya ho amoheloa ha mmaraka le mekhoa ea ts'ebeliso., ho fana ka temohisiso ea bohlokoa mabapi le boteng ba barekisi, joalokaha ho hlalositsoe ho CiteAb's tlhahlobo ea tlhahiso ea lihlahisoa tsa mahlale a bophelo. Ho qotsa linomoro tse hlakileng tsa lethathamo la lihlahisoa, linomoro tsa lotho, le li-RRID li tiisa hore lithaka tsa saense li ka tseba boitsebiso bo ka sehloohong, joalo ka ha ho hlalositsoe ho Tataiso ea StressMarq mabapi le litemana tsa sehlahisoa sa RRID.
Leha ho le joalo, qotso ea lingoliloeng e tlaleha seo sehlopha sa lipatlisiso se ileng sa se reka-ha se netefatse hore reagent e netefalitsoe ka boikemelo pele liteko tsa bona li phatlalatsoa..
Key Takeaway: Tlhaloso e hlahlobiloeng ke lithaka e tiisa hore mohloli o itseng oa morekisi o sebelisitsoe thutong e hatisitsoeng, empa ha e nke sebaka sa 'mele o itseng, tatelano, kapa netefatso e sebetsang ka laboratoring ea hau.
Lithuso tsa Litšehetso tsa Ketsahalo ea Khoebo le Ponahalo ea Brand
Litšehetso tsa liketsahalo-joaloka maphephe a barekisi lisymposiamong tsa bohlokoa, lithupelo tsa tekheniki tse tšehelitsoeng, kapa lithuso tsa maeto tsa mahlale—li sebetsa feela e le matšoao a ponahalo ea khoebo. Ts'ehetso e bonts'a bokhoni ba ho bapatsa ba morekisi, eseng bohloeki ba tlhahlobo kapa ts'epahalo ea ts'ebetso ea li-reagents tsa bona tsa tlhaho.
Ho itšetleha ka botumo ba mofuta oa barekisi kapa ho qotsa lingoliloeng khafetsa joalo ka sebaka sa taolo ea boleng ba kahare ho baka kotsi e kholo ea bophelo., haholo-holo litseleng tse thata tsa taolo joalo ka pontšo ea MDM2/p53.
Thuto-pale: GenScript pcDNA3 Expression Constructs in MDM2/p53 Signaling Research
Ho utloisisa hore na li-vector tse boletsoeng ka lingoliloeng li ka hlahisa phapang ea liteko joang, nahana ka tšebeliso ea GenScript pcDNA3 expression constructs in MDM2 research.
Toba metsotso e 'meli 2 (MDM2) ke E3 ubiquitin ligase e sebetsang e le taolo e mpe ea p53 tumor suppressor protein.. Litsamaisong tsa mofuta o hlaha oa p53, MDM2 e tlama sebaka sa N-terminal transactivation ea p53, e e lebisitse bakeng sa ho senyeha ha proteasomal ka mokhoa o tiileng oa maikutlo a fosahetseng, joalo ka ha ho hlalositsoe ka botlalo ho tlhahlobo e felletseng ho Moralo oa Hona joale oa Pharmaceutical. Hobane MDM2 overexpression e ka hatella ts'ebetso ea p53 ntle le phetoho e tobileng ea liphatsa tsa lefutso, Bafuputsi ba atisa ho fetisetsa li-plasmids tsa recombinant MDM2 ho hlahloba ho tšoaroa ha lisele tsa lisele, apoptosis, kapa li-inhibitors tse nyenyane tsa molek'hule MDM2-p53.
pcDNA3 Expression Vector Backbone CMV Promoter → Epitope Tag → MDM2 Insert → BGH PolyA (E hatisitsoe ke p53) (E ka fetola E3) (RING Domain) (Ho tsitsa ha sengoloa)
Li-Plasmids tse kang pcDNA3 MDM2 WT li thathamisitsoe libakeng tse ngata tsa polokelo ea thuto, ho kenyeletsa polokelongtshedimosetso ya polokelo ya Addgene pcDNA3 MDM2 WT, 'me e entsoe bocha kapa ea fetoloa ke barekisi ba khoebo joalo ka GenScript. The pcDNA3 vector mokokotlo (5.4 kb) E sebelisa cytomegalovirus ea motho (CMV) motšehetsi oa pele-pele oa polelo ea boemo bo holimo ea lianyesi, tšimoloho ea SV40 bakeng sa replication ea episomal ho SV40 e kholo ea T-antigen e hlahisang lisele tse amohelang (joalo ka HEK293T), le lesupa la khetho ea neomycin/G418.
Artifact ea Teko 1: Khatello ea Mokhatlalatsi oa CMV ka Wild-Type p53
Kotsi e kholo lithutong tsa polelo ea MDM2 e kenyelletsa taolo ea batšehetsi. Le ha mothetsi oa CMV ho pcDNA3 a ts'oaroa joalo ka motšehetsi ea matla oa constitutive, Boithuto bo matla bo bonts'a hore ts'ebetso ea motšehetsi oa CMV e hatelloa ka matla ke maemo a phahameng a mofuta oa p53., joalokaha ho bontšitsoe ho phuputso e phatlalalitsoeng ho Journal of Biological Chemistry. Rasa Research Peptides Supplies
Ha bafuputsi ba fetisetsa pcDNA3-MDM2 liseleng tse nang le pontšo e tsitsitseng ea p53, ho phahama ha maemo a p53 ho hatella moetapele oa CMV, e bakang ho se thale, ho itšehla thajana ha MDM2 polelo. Haeba sehlopha sa lipatlisiso se nka ts'ebetso ea kamehla ea batšehetsi se ipapisitseng le litemana tse qotsitsoeng, Liphetoho tsa bongata ba liprotheine tsa MDM2 li ka 'na tsa se ke tsa hlahisoa ka mokhoa o fosahetseng ka lebaka la ho sebetsa ha metsoako ea liteko kapa ho senyeha ka morao ho phetolelo ho e-na le khatello ea batšehetsi..
Bench Case Note (MOL E Fetola Lab ea Taolo ea Boleng): Ts'ebelisong ea tloaelo ea li-orthogonal cross-sourced pcDNA3 plasmid constructs., tatellano ea bidirectional Sanger ho pholletsa le likhokahano tsa motšelisi-kenya tse bonts'itsoeng mefuta e sa lebelloang ea nucleotide e le 'ngoe (SNVs) ka hare ho sebaka sa CMV hang-hang-pele. Lits'oants'o tsena tse nyane tsa tatellano li bakile phokotso ea ~ 35% ea ts'ebetso ea motšehetsi oa mantlha mefuteng ea lisele tse hlaha ha li bapisoa le limmapa tsa litšupiso tsa NCBI - e bonts'a hore na hobaneng netefatso ea tatellano ea liphatsa tsa lefutso e le tlamo pele e etsa liteko tsa cellular tse tlase..
Artifact ea Teko 2: Epitope Tagging le RING-Finger Domain Alterations
Ho latela recombinant MDM2, hangata li-vector tsa khoebo li hlomathisa li-tag tsa N-terminal kapa C-terminal epitope (joalo ka Myc, FALAKA, kapa GFP). MDM2 e itšetlehile ka sebaka sa eona sa C-terminal RING-finger bakeng sa ts'ebetso ea E3 ubiquitin ligase le homodimerization.. Li-peptide tse tloaelehileng
Haeba morekisi oa khoebo a fetola mateano a cloning kapa tag e kentsoe haufi le sebaka sa RING-finger ntle le netefatso e matla ea sebopeho., protheine ea fusion e hlahisitsoeng e ka bonts'a ts'ebetso e fokotsehileng ea E3 ligase kapa e fetotsoe ka mokhoa o ikhethileng oa substrate. Tatellano ea Sanger ea li-junctions tsa ho kenya le orthogonal mass spectrometry lia hlokahala ho netefatsa hore tag ha e so sitise ho menaha ha domain..
Likotsi Tse Patehileng Tsa Lisebelisuoa Tse Sebelisitsoeng Lingoliloeng: Sequence Drift, Tšitiso ea Tag, le Phapang ea Batch
Ho amohela li-reagents tse boletsoeng ka lingoliloeng ntle le netefatso ho hlahisa mekhoa e meraro e meholo ea ho hloleha ha tekheniki:
- Liphetoho tse sa Lekanyetsoang le Sequence Drift: Li-Plasmids tse phatlalalitsoeng ho pholletsa le mefuta ea libaktheria li ka bokella liphetoho tse fetohang, kenyeletso, kapa likarolo tsa transposon. Ho fetisa li-preps tsa plasmid ntle le tatellano ea meeli ea ho kenya ho ka fetola matla a motšehetsi kapa ho hlahisa liphetoho tse khutsitseng / tse fosahetseng ka foreimi ea likhoutu..
- Litšila tsa Peptide le Reagent: Ka peptide synthesis (joalo ka MDM2-binding helical peptides kapa p53-derived tracer peptides), barekisi ba khoebo ba ka fana ka lisebelisoa tse nang le tatelano e khutsufalitsoeng ea ho hlakola ((n-1) kapa (n-2) li-isomers) haeba tlhoekiso e sa lekana. Li-peptide tsa maiketsetso tse sa hloekang li ka baka kinetics e tlamang e fosahetseng ho resonance ea plasmon. (SPR) kapa polarization ea fluorescence (FP) liteko.
- Liphapang tsa CoA le ho hloka botsitso ha Lota: Litifikeiti tsa Tlhahlobo (CoAs) e fanoeng ke barekisi e ka 'na ea emela liteko tsa khale tsa sehlopha ho fapana le vial e isitsoeng laboratoring ea hau. Ntle le ho netefatsa traceability ea lotho le ho leka botsitso ba polokelo, liphapang tsa bohloeki tse ngata ho tse ngata li ka sitisa ho ikatisa ha bongata.
Bakeng sa Keletso: Le ka mohla u se ke ua nahana hore Setifikeiti sa Tlhahlobo sa khoebo se bonts'a boemo ba hona joale ba 'mele oa reajente ka mor'a ho tsamaea. Kamehla etsa tlhahlobo ea boitsebiso ba ka hare le ho hloeka ha u fumana.
Porothokhole e Ikemetseng ea netefatso ea Methati e 3 bakeng sa Lisebelisuoa tse Tsoang Lingoliloeng
Ho sireletsa merero ea lipatlisiso ho li-artifact tse sa netefatsoang tsa reagent, lilaboratori li lokela ho theha maemo a tloaelehileng, mehato e meraro ea orthogonal netefatso ea tšebetso.
Sethala 1: Tlhahlobo ea Leloko → Sethala 2: Tatelano & QC ea 'mele → Sethala 3: Litaolo tsa Ts'ebetso
(CoA & KE BATLA Check) (Sebini/NGS & RP-HPLC/MS) (p53-null & Litlhahlobo tsa Proteasome)
Sethala 1: Tlhahlobo ea Lineage le Lot Traceability
Pele o hatsetsa kapa o fetisetsa mochini o mocha oa vector kapa peptide ea maiketsetso, netefatsa litokomane tsa eona tse felletseng:
- Rekota Metadata ea Boitsebiso: Ngola lebitso la morekisi, nomoro e nepahetseng ea lethathamo, clone ID, nomoro ea batch/lotho, le RRID.
- Hlahloba 'mapa oa barekisi le CoA: Bapisa 'mapa oa plasmid o fanoeng ke morekisi kapa
Ka li-peptides Theha Leloko la Freezer: Bakeng sa li-plasmids, lekola mofuta oa baktheria, mohopolo oa khetho ea lithibela-mafu, le palo ea palo ho tloha phetohong ea mantlha.
mohopolo oa khetho ea lithibela-mafu, le palo ea palo ho tloha phetohong ea mantlha.
Sethala 2: Tatelano ea Orthogonal le Sebopeho sa 'Mele
Netefatso ea 'mele le liphatsa tsa lefutso e tlameha ho etsoa pele ho etsoa litlhahlobo tsa baeloji:
- Sanger Sequencing: Etsa tatellano ea bidirectional ea Sanger ho pholletsa le likhokahano tsohle tsa batšehetsi-kenya, li-tag tsa epitope, le libaka tsa boenjiniere tsa phetoho.
- Tatelano ya Moloko o Latelang (NGS): Bakeng sa rarahaneng, telele, kapa li-vector tse ngata tsa cistronic, sebedisa tatelano ya nako e telele (joalo ka Oxford Nanopore kapa PacBio) ho bona li-quasispecies tsa maqhubu a tlase kapa litlhophiso tsa mokokotlo tseo tatellano ea Sanger e ka fosang.
- RP-HPLC le Mass Spectrometry (MOF) bakeng sa li-Peptides: Ha u sebelisa li-reagents tsa peptide tsa maiketsetso, sekaseka sampole u sebelisa analytical C18 Reverse-Phase HPLC (0.1% TFA ho H₂O/ACN gradient) ho etsa bonnete ba hore tharollo e phahameng (Rₛ ≥ 1.5) le bohloeki (≥ 98%). Netefatsa boima ba limolek'hule u sebelisa High-Resolution Electrospray Ionization Mass Spectrometry (ESI-MS) ka phoso ea bongata tlasa 5 ppm.
Bakeng sa lilaboratori tse batlang mokhoa o tšepahalang oa ho kopanya le ho netefatsa, sebelisa a sethaleng se tloaelehileng sa peptide synthesis e tšehelitsoe ka botlalo HPLC ea tlhahlobo le lits'ebeletso tsa tlhahlobo ea spectrometry e etsa bonnete ba hore tatellano e 'ngoe le e' ngoe e fanoeng e ba le matšoao a thata pele a sebelisoa.
Sethala 3: Litaolo tsa Tsela e Sebetsang
Netefatso ea bioloji e tiisa hore protheine e hlahisitsoeng kapa peptide e kopaneng e sebetsa ka nepo maemong a cellular a shebiloeng:
- Netefatso ea Polelo le Boholo: Etsa tlhahlobo ea Western blot kapa immunoprecipitation ho netefatsa hore mohaho o hlalositsoeng o lumellana le boima ba molek'hule bo boletsoeng esale pele ntle le lihlahisoa tse senyehang tse neng li sa lebelloa..
- Litaolo tsa Melaetsa ea Liphatsa tsa lefutso: Ha u lekola li-constructs tsa MDM2, kenyeletsa p53-null cell line (joalo ka Saos-2 kapa H1299) haufi le mela ea p53-wildtype (joalo ka MCF-7 kapa U2OS) ho khetholla chefo e itšetlehileng ka p53 ho liphello tsa vector tse sa lebelloang.
- Proteasome Inhibition Assays: Phekola lisele tse tšoaelitsoeng ka li-proteasome inhibitors (joalo ka MG132) ho netefatsa hore phokotso ea MDM2-mediated p53 e ka pholosoa, ho theha ts'ebetso ea E3 ligase e sebetsang.
Moralo oa Tabular: Lethathamo la Teko la Laboratori bakeng sa netefatso ea Reagent le Phetiso
Lethathamo le latelang la tlhahlobo le fana ka moralo o hlophisitsoeng oa
Netefatso Fektheri e Tšepahalang ea Peptide Company Sethala
li-vector tse qotsitsoeng le li-reagents tsa peptide tsa tloaelo pele ho ts'ebetso ea liteko:
| Mothati oa ho netefatsa | Paramethara / Teko | Mekhoa ea ho Amohela | Artifact ea mathomo Thibeloa |
|---|---|---|---|
| Sethala 1: Leloko | Lot Traceability & CoA Audit | Nomoro ea batch e bapisang
Liraglutide Api Supplier Manufacturer 100% boitsebahatso ba tatellano ho pholletsa le mothasi, li-tag, le ho kenya meeli > Ho fumana li-isoform tsa plasmid tse fosahetseng kapa lintho tse fetotsoeng tsa lethathamo |
|
| Sethala 2: Tatelano | Sanger / NGS Junction Sequencing | 100% boitsebahatso ba tatellano ho pholletsa le mothasi, li-tag, le ho kenya meeli | Liphetoho tsa li-frame-shift, ntlha ya liphetoho, le ho hlakolwa ha mateano |
| Sethala 2: QC ea 'mele | RP-HPLC Tlhahlobo ea Bohloeki | Tlhōrō e le 'ngoe e bohale ea chromatographic, bohloeki ≥ 98%, Rₛ ≥ 1.5 | Tatelano e khutsufalitsoeng ea ho hlakola (n-1) le synthesis lehlakoreng-lihlahisoa |
| Sethala 2: Boholo ba QC | Boemo bo phahameng ESI-MS Peptide Synthesis | Ho nepahala ha boima ba Monoisotopic ka hare < 5 ppm ea boima ba theoretical | Liphetoho tse fosahetseng tsa amino acid kapa ts'ireletso e sa phethahalang |
| Sethala 3: E sebetsang | Blot ea Bophirimela & Netefatso ea Polelo | Sehlopha se nepahetseng sa boima ba molek'hule; ha ho lihlahisoa tse sa lebelloang tsa cleavage | Ho haella ha protheine, ho senyeha ka potlako, kapa ho hloleha ha puo e thotseng |
| Sethala 3: Tsela | Isogenic & Null Cell Controls | Phapang e hlakileng ea ts'ebetso ho p53-wildtype vs. P53-null lisele | Tlhahiso e fosahetseng ea chefo ea vector ho matshwao a tsela e itseng |
Ho Sireletsa Boikemisetso ba Teko ho Vector ea Tloaelo le Peptide R&D
Lingoliloeng tse qotsitsoeng li fana ka sebaka sa ho qala bakeng sa khetho ea reagent, empa li ke ke tsa nka sebaka sa taolo ea boleng ba kahare. Joalo ka ha lipatlisiso tsa biomedical li tobane le tlhahlobo e ntseng e hola holim'a tlhahiso ea data, lilaboratori tse ikemetseng tse netefatsang kaho e 'ngoe le e' ngoe ea vector le sehlopha sa peptide li sireletsa matsete a tsona a benche, thibela lihora tse senyehileng tsa lipatlisiso, le ho etsa bonnete ba hore liqeto tse phatlalalitsoeng li lula li tiile.
Ha u batla lisebelisoa tse khethehileng kapa u phahamisa tatellano e tloaelehileng, ho sebetsa le molekane wa tlhahlobisiso ya sebetsang ka hare Sehlopha 100 meaho e hloekileng ea likamore e netefatsa hore tšilafalo le li-endotoxin tsa tikoloho li tlosoa tlhahisong. Ho feta moo, leveraging litharollo tse khethehileng tsa peptide CRO e lumella lihlopha tsa bafuputsi ho fumana thepa e ngotsoeng ka botlalo-e tšehetsoeng ke li-chromatogram tsa HPLC, ESI-MS spectra, le li-CoA tse khethehileng-pele ho qala litlhahlobo tsa lisele tsa bohlokoa.
Ka ho kopanya tlhahlobo ea bohlokoa ea lingoliloeng le protocol e tiileng ea mehato ea 3, lilaboratori tsa lipatlisiso li ka sebelisa lisebelisoa tse qotsitsoeng lingoliloeng ka boits'epo ha li ntse li sireletsa bots'epehi le ho hlahisa tlhahiso ea bona ea mahlale..
Mehato e latelang ea R&D lihlopha
U hloka sebopeho se ikemetseng kapa synthesis ea peptide ea bohloeki bo phahameng bakeng sa lipeipi tsa hau tsa lipatlisiso? Ikopanye le litsebi tsa analytical ho MOL Changes ho kopa tlhahlobo ea tekheniki, hlahloba litekanyetso tsa tlhahlobo ea tlhahlobo, kapa hlahloba litharollo tsa tloaelo tse tsamaellanang le litlhoko tsa hau tsa liteko.
Mabapi le Bahlahlobi ba Mahlale
Tataiso ena ea tekheniki e ngotsoe le ho hlahlojoa ke ba MOL E Fetola Boto ea Keletso ea Saense & Sehlopha sa Lipatlisiso- sehlopha se kopaneng sa litsebi tsa k'hemistri tse phahameng tsa peptide, litsebi tsa baeloji ea limolek'hule, le litsebi tsa tlhahlobo ea QC. Ho sebetsa ka har'a Sehlopha 100 meaho e hloekileng ea likamore, sehlopha sa MOL Changes se sebetsa ka mokhoa o ikhethileng moralong oa tatellano ea peptide, microbial/solid-phase synthesis, le netefatso e matla ea tlhahlobo e khethehileng (RP-HPLC, ESI-MS, le tlhahlobo ea sterility) ho tšehetsa lipatlisiso tsa mahlale tse ka ikatisang.
